Technical Developments Sample Clauses

Technical Developments. Biocept shall keep Life Technologies fully informed as to all discoveries and technical developments (including, without limitations, any inventions) made by Biocept during the Term related to the Tests.
Sample 1Sample 2Sample 3See All (10)
AutoNDA by SimpleDocs
Technical Developments. Clarient shall keep Biocept fully informed as to all discoveries and technical developments (including, without limitations, any inventions) made by Clarient during the Term related to the Diagnostic Tests.
Sample 1Sample 2Sample 3See All (8)
Technical Developments. In recognition of ongoing development in the area of discovery of scholarly resources, the JSTOR, Licensee, and its Members shall cooperate in communicating about possible further uses of Metadata in connection with such developments. Notwithstanding the foregoing, nothing set forth herein shall obligate either party to agree to modify the Scope of Use of the Metadata as described herein.
Sample 1
Technical Developments. To enable a continuous integration in the whole workflow system, we implemented a Silk Web service. This Web service acts like every other Web service in OmNom. It takes as input a URI to a Silk configuration file and generates the links based on this configuration. Therefore, we used the Silk Single Server Machine and built our implementation around it to fit our needs. Usually, Silk takes as input in the configuration either a local RDF dump or a SPARQL endpoint. Since the user cannot manually upload any files on our server, it is not possible to specify RDF dumps but not every resource has a SPARQL endpoint. Thus, we need to provide the possibility to specify URIs as input in the configuration. Whenever an URI is given, we download the content and write it into a local file on the server. Afterwards, we internally rewrite the configuration and replace it with the local file input. With this workaround, we enable the usage of URIs as input without the need to directly adapt Silk. Nevertheless, the input sources must either be available via a SPARQL endpoint or be provided as an RDF dump in the Web. Furthermore, the Silk configuration file must also be accessible via a URI. As result of the Silk Web service, a linkset is created, containing the links between the instances. These linksets can then be published in the triple store similar to the ingested data. Using the Linked Data API, whole linksets can be displayed or only the links which have been generated for a certain instance. Thus, additional information about the instances is provided. Using the linksets, it is obvious that the links have been generated by Silk and were not included in the ingested data itself. Moreover, also the provenance of the matching can be inspected to get to know which configuration has been used to create the according links. The deployed Silk tool is the latest stable version 2.5.3 (from March 6, 2012)20. Documentation for the tool in general can be found in the Silk wiki at xxxxx://xxx.xxxxxxxx.xxx/spaces/silk/wiki/Home. Information about the deployment in DM2E can be found in the developer documentation (see Section 10.2). The software was deployed on a Tomcat 7 Web container configured to run with the options JAVA_OPTS="-Djava.awt.headless=true -Xms2048m -Xmx8192m -XX:PermSize=1024m - XX:MaxPermSize=1024m”, that is, a maximum use of 8GB of RAM. Depending on the use of the machine, the maximum amount of allocated RAM can still be raised later on, seeing the total of 16...
Sample 1
Technical Developments. 10.1 The intellectual property rights to any improvements to the Products produced by TF Ltd shall be the property of TF Ltd. TF Ltd agrees that the irrevocable exclusive rights to manufacture and market such improvements outside the Territory will ~e assigned back to TF Inc. on a similar royalty free basis to the assignment granted herein save that TF Ltd gives no warranty as to it's ability to grant such rights or that the exploitation of the same will not infringe the rights
Sample 1

Related to Technical Developments

  • Clinical Development Licensee will have sole responsibility for and sole decision making over the clinical development of any Product arising from the Research Program in the Field. Notwithstanding the foregoing, if Licensee wishes to conduct clinical development of a Development Candidate at Penn and Penn has the clinical expertise, interest and ability to run such a trial as assessed at Penn’s sole discretion, such a study will be conducted under a separate Clinical Trial Agreement to be negotiated by the Parties prior to initiation of such study. Such separate clinical trial agreement will include a detailed clinical development plan, including costs and time lines for conducting the Clinical Trial.

  • Research and Development (i) Advice and assistance in relation to research and development of Party B;

  • Joint Development If joint development is involved, the Recipient agrees to follow the latest edition of FTA Circular 7050.1, “Federal Transit Administration Guidance on Joint Development.”

  • Business Development Provide advice and assistance in business growth and development of Party B. 业务发展。对乙方的业务发展提供建议和协助。

  • New Developments All ideas, inventions, discoveries, concepts, trade secrets, trademarks, service marks or other developments or improvements, whether patentable or not, conceived by Employee, alone or with others, at any time during the term of Employee’s employment, whether or not during working hours or on Employer’s premises, which are within the scope of or related to the business operations of Employer or its Affiliates (“New Developments”), shall be and remain the exclusive property of Employer. Employee agrees that any New Developments which, within one year after the cessation of employment with Employer, are made, disclosed, reduced to a tangible or written form or description or are reduced to practice by Employee and which are based upon, utilize or incorporate Information shall, as between Employee and Employer, be presumed to have been made during Employee’s employment by Employer. Employee further agrees that Employee will not, during the term of Employee’s employment with Employer, improperly use or disclose any proprietary information or trade secrets of any former employer or other person or entity and that Employee will not bring onto Employer premises any unpublished document or proprietary information belonging to any such employer, person or entity unless consented to in writing by such employer, person or entity. At all times during the term of this Agreement and thereafter, Employee shall do all things reasonably necessary to ensure ownership of such New Developments by Employer, including the execution of documents assigning and transferring to Employer all of Employee’s rights, title and interest in and to such New Developments and the execution of all documents required to enable Employer to file and obtain patents, trademarks, service marks and copyrights in the United States and foreign countries on any of such New Developments.

  • Initial Development Plan Not later than the Effective Date, Licensee shall have provided Merck with an initial Development plan for the Licensed Product in the Field in the Territory, which shall be incorporated as part of this Agreement as Attachment 3.02(a) (as may be amended in accordance with this Agreement, the “Development Plan”). **CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND WILL BE FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO A CONFIDENTIAL TREATMENT REQUEST.

  • Adverse Developments Promptly after the Lessee acquires knowledge thereof, written notice of:

  • Product Development Attach all requested documentation and attach additional pages as necessary. For all requirements include efforts of all Sublicensees. If not applicable, please so indicate by N/A.

  • Manufacturing Technology Transfer With respect to each Technology Transfer Product, upon AbbVie’s written request after the Inclusion Date for the Included Target to which such Technology Transfer Product is Directed, Morphic shall effect a full transfer to AbbVie or its designee (which designee may be an Affiliate or a Third Party manufacturer) of all Morphic Know-How and Joint Know-How relating to the then-current process for the Manufacture of such Technology Transfer Product (the “Manufacturing Process”) and to implement the Manufacturing Process at facilities designated by AbbVie (such transfer and implementation, as more fully described in this Section 5.3, the “Manufacturing Technology Transfer”). To assist with the Manufacturing Technology Transfer, Morphic will make its personnel reasonably available to AbbVie during normal business hours for up to [***] FTE hours with respect to each Included Target (in each case, free of charge to AbbVie) to transfer and implement the Manufacturing Process under this Section 5.3. Thereafter, if requested by AbbVie, Morphic shall continue to perform such obligations; provided, that AbbVie will reimburse Morphic for its full-time equivalent (FTE) costs (for clarity, in excess of [***] FTE hours) and any reasonable and verifiable out-of-pocket costs incurred in providing such assistance. CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED.

  • Regulatory Affairs Development and production of medical products and processes fall under the purview of the Food and Drug Administration (FDA) and research on these products involving animal or human studies is regulated by other laws, directives, and regulations. Project Awards under this Agreement that involve work in support of or related to FDA regulatory approval will address contingencies for Government access to regulatory rights in the event of product development abandonment or failure. Efforts conducted under this OTA shall be done ethically and in accordance with all applicable laws, directives, and regulations. The Government shall ensure performance includes regulatory expertise and guidance for candidate medical countermeasure development efforts:

Time is Money Join Law Insider Premium to draft better contracts faster.